Description

Bioven Infusion (Human Normal Immunoglobulin) Solution 10% 100 ml Bottle №1

Ingredients:

Each 100 ml bottle contains Human Normal Immunoglobulin 10g.

Dosage:

The dosage of Bioven infusion should be determined by a healthcare professional based on the patient’s condition and response to treatment. It is typically administered intravenously.

Indications:

Bioven infusion is indicated for the treatment of primary immunodeficiency disorders, autoimmune deficiencies, and certain neurological conditions. It works by providing the body with the necessary antibodies to strengthen the immune system.

Contraindications:

Do not use Bioven infusion if you have a history of severe allergic reactions to human immunoglobulins or any of the components in the product. It is important to inform your healthcare provider of any allergies before starting treatment.

Directions:

Bioven infusion should be administered by a healthcare professional in a clinical setting. The infusion rate and duration will be determined by the healthcare provider based on the patient’s condition.

Scientific Evidence:

Studies have shown that Bioven infusion is effective in boosting the immune system in patients with immunodeficiency disorders. Research published in the Journal of Clinical Immunology demonstrated the efficacy of human normal immunoglobulins in managing autoimmune conditions.

Additional Information:

It is important to monitor for any signs of allergic reactions during Bioven infusion administration. Common side effects may include headache, fatigue, and mild fever, which usually resolve on their own.

Pharmacologically, Bioven infusion works by providing a concentrated dose of immunoglobulins, which are essential antibodies that help the body fight infections and regulate the immune response. By supplementing these antibodies, Bioven infusion can help restore immune function in individuals with compromised immune systems.

Clinical trials have shown that Bioven infusion is comparable in effectiveness to other immunoglobulin products on the market. A study published in the Journal of Allergy and Clinical Immunology compared the efficacy and safety profiles of different immunoglobulin preparations and found Bioven to be well-tolerated and effective in managing immunodeficiency disorders.